Latest Updates
Source of inflammation found for Rheumatoid arthritis
Researchers find new details about how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack.
$1.5 million funding for ageing and aged care research
The Australian Government awarded $1.5 million funding to Prof Ruth Hubbard for ageing and aged care research.
New CEO for the Translational Research Institute
The TRI Board has appointed renowned respiratory specialist, Professor Scott Bell as the Institute’s new CEO.
An Australian-first initiative of 'bench to bedside' medical research
The Translational Research Institute (TRI) is a unique, Australian-first initiative of ‘bench to bedside’ medical research. TRI combines clinical and translational research to advance progress from laboratory discovery to application in the community.
The work conducted at TRI is translational research, a research process which involves teams of patients, clinicians and researchers working together to solve health challenges faster. The work is driven by the needs of patients, a question formed by a clinician and a solution sought by a scientist.
What is Translational Research?
Also known as 'bench-to-bedside' research, it is a type of medical research that focusses on 'translating' basic science discoveries from the laboratory into the clinic.
The aim is to improve how we detect, diagnose and treat health conditions, and improve health outcomes for patients.
At TRI, we work to develop new treatments and diagnostics for conditions ranging from various cancers to autoimmune diseases, and translate these discoveries into improved healthcare.
What's On
Toolbox Talks
These regularly scheduled events will give you the tools you need to make the most of the facilities and equipment...
Cancer Seminar Series
The Cancer Seminar Series showcases research from our TRI partner institutes- UQ Diamantina, QUT and the Mater and...
